- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 10.01. | Baillie Gifford US Growth Trust - A unique high-growth strategy meriting support | 244 | Baillie Gifford US Growth Trust (USA) invests in exceptional US businesses with the potential to grow substantially faster than the market and deliver above-market returns. Such businesses tend to operate... ► Artikel lesen | ||
| 09.01. | Greggs - More challenging environment in H224 | 307 | Greggs has reported that FY24 profit is in line with management's expectation despite the more challenging environment and slowing sales growth through H224. The more challenging market means that management... ► Artikel lesen | ||
| 09.01. | BlackRock Greater Europe Investment Trust - Positive prospects for high-quality portfolio | 342 | BlackRock Greater Europe Investment Trust (BRGE) is one of six funds in the AIC Europe sector. Co-managers Stefan Gries and Alexandra Dangoor note that although BRGE delivered a modest below-market... ► Artikel lesen | ||
| 08.01. | Topps Tiles - further improvement in trading at end of Q125. CEO retiring from company | 230 | Topps Tiles has reported an encouraging trading update that shows a good acceleration in the rate of year-on-year sales growth in the most recent five weeks of Q125 to continue the previously indicated... ► Artikel lesen | ||
| 03.01. | Mendus - Regulatory endorsement supports vididencel focus | 280 | Mendus's lead asset, vididencel, is fast approaching the pivotal stages of development in acute myeloid leukaemia (AML), with recent endorsements from both the FDA and EMA (on the design of the planned... ► Artikel lesen | ||
| 02.01. | Melrose Industries - Fundamentals remain positive | 297 | The aerospace sector outlook remains positive, with lengthy order books at the primes (Airbus and Boeing) and total passenger flying hours in 2024 on schedule to exceed post-pandemic levels, supporting... ► Artikel lesen | ||
| 20.12.24 | OPAP - Winning strategy | 918 | OPAP enjoys a leading and growing position in the Greek and Cypriot gaming markets. The majority of its revenue, from land-based activities, is supported by exclusive prepaid licences. To complement... ► Artikel lesen | ||
| 20.12.24 | Patria Private Equity Trust - High liquidity and solid long-term track record | 421 | Patria Private Equity Trust's (PPET's) distributions from its primary fund investments have increased recently, supported by a revival in private equity (PE) deal activity. Its portfolio valuations... ► Artikel lesen | ||
| 20.12.24 | MoneyHero - Emphasis on driving margin | 281 | MoneyHero's Q324 results show revenues up 6% y-o-y (9M24 +18%) and a smaller adjusted EBITDA loss, as expected. The important element of the narrative, though, is the emphasis on driving revenues in... ► Artikel lesen | ||
| 19.12.24 | Intralot - Continuing improvement in Q324 | 319 | Intralot's (INLOT's) Q324 results demonstrated good underlying revenue growth, which was offset by one-offs and negative foreign exchange differences, and a typical seasonal and sequential (ie quarter-on-quarter)... ► Artikel lesen | ||
| 19.12.24 | Picton Property Income - Delivering on key initiatives | 324 | Since reporting H125 results, Picton has agreed the sale of an office asset designated for alternative use, completed the small but accretive acquisition of an industrial unit, and undertaken several... ► Artikel lesen | ||
| 19.12.24 | 1Spatial - Wins in the utilities sector for AI-supported apps | 273 | 1Spatial has secured several new contracts in the utility sector for its AI-supported applications, highlighting the opportunity for it to enable the digitisation of the utilities industry. The deals... ► Artikel lesen | ||
| 18.12.24 | Mendus - Vididencel shines in ALISON trial (ovarian cancer) | 258 | Mendus has reported positive top-line data for its Phase I ALISON trial, which is evaluating lead off-the-shelf cancer vaccine, vididencel, in high-grade serous ovarian carcinoma (HGSC). The news corresponds... ► Artikel lesen | ||
| 18.12.24 | Deutsche Beteiligungs - Strengthened balance sheet for new opportunities | 931 | Deutsche Beteiligungs (DBAG) reported an 8.5% NAV total return (TR) in FY24 (to end-September 2024), supported by positive movements in valuation multiples, which offset the negative impact from changes... ► Artikel lesen | ||
| 18.12.24 | Pan African Resources - Honing FY25e forecasts | 294 | Almost exactly half way through its financial year, Pan African has reiterated its production guidance for FY25 of 215,000oz - not least as a result of c 9,000oz gold produced at MTR in H125 following... ► Artikel lesen | ||
| 17.12.24 | Phoenix Spree Deutschland - Enhanced realisation strategy to unlock value | 347 | Phoenix Spree Deutschland (PSD) has completed the strategic sale of a 16-building portfolio of rental properties. Under its amended financing terms, PSD can now significantly accelerate condominium... ► Artikel lesen | ||
| 17.12.24 | Recce Pharmaceuticals - BPOM clearance to start Phase III R327G study | 291 | Recce received approval from the Indonesian Drug and Food Regulatory Authority, Badan POM (BPOM), to start its registrational Phase III study in Indonesia of RECCE® 327 topical gel (R327G) in diabetic... ► Artikel lesen | ||
| 17.12.24 | Newron Pharmaceuticals - Evenamide licence agreement in Japan | 482 | Newron has entered into a licence agreement with EA Pharma, a subsidiary of Eisai, to develop, manufacture and commercialise evenamide, Newron's proprietary modulator of the excessive release of glutamate... ► Artikel lesen | ||
| 17.12.24 | Basilea Pharmaceutica - Partner in place for US commercialisation of Zevtera | 365 | Following FDA approval in April 2024, Basilea has announced a much-anticipated partnership agreement with Innoviva Specialty Therapeutics for the commercialisation of Zevtera in the US. Deal terms include... ► Artikel lesen | ||
| 17.12.24 | Filtronic - Upgrading on stronger H225 expectations | 332 | Filtronic's H125 trading update confirmed that the company expects to report FY25 results ahead of current market expectations. Robust customer demand has resulted in some orders being pulled forward... ► Artikel lesen | ||
| 16.12.24 | Borussia Dortmund - Taking on the world | 454 | Borussia Dortmund is one of the leading football clubs in Europe, with a strong track record in its domestic league, which has enabled it to feature regularly in Europe's leading club competitions.... ► Artikel lesen | ||
| 16.12.24 | Molten Ventures - Strong firepower to invest into the next cycle | 272 | Molten's portfolio valuations remain stable in H125, illustrated by the limited fair value movements of its core holdings that recently completed new funding rounds, as well as Molten's recent exits... ► Artikel lesen | ||
| 16.12.24 | Canyon Resources - Breaking down the investment case | 276 | Canyon Resources, an ASX-listed exploration and development company, is advancing the high-grade, large-scale Minim Martap bauxite project in Cameroon. Minim Martap, a feasibility-stage project, is... ► Artikel lesen | ||
| 16.12.24 | S&U - Regulatory uncertainty holding back recovery | 255 | S&U's trading update, covering the H225 period up to 10 December 2024, contrasts strong growth in the property lending division with regulatory headwinds for motor finance. Positive news of the lifting... ► Artikel lesen | ||
| 16.12.24 | Carr's Group - At an inflexion point | 258 | Carr's Group plan to dispose of the Engineering businesses remains on track and will leave the company as a focused agricultural supplies business. Restructuring (both the cost base and exiting loss-making... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
